Manulife (Manufacturers Life Insurance)’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $118K | Buy |
32,741
+2,172
| +7% | +$7.82K | ﹤0.01% | 2728 |
|
|
2025
Q1 | $91.4K | Sell |
30,569
-1,772
| -5% | -$5.3K | ﹤0.01% | 2714 |
|
|
2024
Q4 | $108K | Sell |
32,341
-1,213
| -4% | -$4.06K | ﹤0.01% | 2802 |
|
|
2024
Q3 | $112K | Sell |
33,554
-1,332
| -4% | -$4.46K | ﹤0.01% | 2836 |
|
|
2024
Q2 | $115K | Buy |
34,886
+4,339
| +14% | +$14.4K | ﹤0.01% | 2788 |
|
|
2024
Q1 | $123K | Sell |
30,547
-2,438
| -7% | -$9.85K | ﹤0.01% | 2731 |
|
|
2023
Q4 | $101K | Hold |
32,985
| – | – | ﹤0.01% | 2817 |
|
|
2023
Q3 | $99K | Buy |
32,985
+46
| +0.1% | +$138 | ﹤0.01% | 2812 |
|
|
2023
Q2 | $123K | Buy |
32,939
+2,532
| +8% | +$9.47K | ﹤0.01% | 2768 |
|
|
2023
Q1 | $102K | Sell |
30,407
-189,700
| -86% | -$635K | ﹤0.01% | 2740 |
|
|
2022
Q4 | $1.06M | Buy |
220,107
+310
| +0.1% | +$1.49K | ﹤0.01% | 1580 |
|
|
2022
Q3 | $1.25M | Sell |
219,797
-511
| -0.2% | -$2.91K | ﹤0.01% | 1516 |
|
|
2022
Q2 | $1.56M | Sell |
220,308
-38,347
| -15% | -$272K | ﹤0.01% | 1482 |
|
|
2022
Q1 | $1.86M | Buy |
258,655
+35,000
| +16% | +$252K | ﹤0.01% | 1529 |
|
|
2021
Q4 | $2.01K | Sell |
223,655
-59,768
| -21% | -$537 | ﹤0.01% | 1497 |
|
|
2021
Q3 | $9.94M | Sell |
283,423
-3,417
| -1% | -$120K | 0.01% | 934 |
|
|
2021
Q2 | $6.16M | Buy |
286,840
+27,364
| +11% | +$588K | 0.01% | 1180 |
|
|
2021
Q1 | $16M | Buy |
259,476
+1,191
| +0.5% | +$73.5K | 0.01% | 750 |
|
|
2020
Q4 | $10.8M | Buy |
+258,285
| New | +$10.8M | 0.01% | 859 |
|